TrialArthritis & rheumatology (Hoboken, N.J.)2018

Long-Term Safety and Efficacy of Belimumab in Patients With Systemic Lupus Erythematosus: A Continuation of a Seventy-Six-Week Phase III Parent Study in the United States.

Richard A Furie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.